Table 5. Prosate Cancer Databases for external validation of selected proteins.

Database	Samples	Clinical Data	Details	Matching Genes (LG)	CI (LG)	Survival ROC (LG)	Matching Genes (AS)	CI (AS)	Survival ROC (AS)
Taylor MSKCC Prostate	140	Recurrence, Gleason, Stage	Concordant assessment of DNA copy number, mRNA expression, and focused exon resequencing in 218 prostate cancer tumors	31/31	82.27	0.85	36/36	83.17	0.82
Galsky Oh - Prostate - GSE45705	61	Survival	qPCR profiling of whole blood from patients with castration-resistant prostate cancer	2/31	52.92	0.44	1/36	53.86	0.65
Sboner Rubin Prostate GSE16560	281	Gleason	cDNA-mediated gene expression profiling on formalin-fixed paraffin-embedded transurethral resection of prostate (TURP) samples	22/31	67.49	0.78	31/36	63.39	0.67
Gulzar-Prostate-GSE40272	98	Recurrence	Gene-expression profiling of prostate tumors	31/31	80.90	0.93	36/36	79.34	0.82
Kollmeyer-Jenkins Prostate GSE10645-GPL5858	596	Survival, Age, PSA, Stage, Grade	Gene expression microarray of tumors using RNA from archival FFPE tissue	2/31	55.89		7/36	69.92	0.76
PRAD - TCGA - Prostate adenocarcinoma June 2016	497	Survival	Gene-expression profiling of prostate tumors	31/31	95.08	0.87	36/36	95.65	0.88

LG = Low Glucose; CI = Concordance index; ROC = Receiver operating characteristic; AS = Androgen Sensitivity